Childrens National Health Center

Washington D.C., District of Columbia 20010

1 studies enrolling now · 4 studies all time

What they study most

LGI1 Autoimmune Encephalitis, Multiple Sclerosis, NMDAR Autoimmune Encephalitis, Pain Crisis, Peanut Allergy

Studies at this site

• Natural History of Sickle Cell Disease — Recruiting now
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis — Running, not enrolling
• A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis — Running, not enrolling
• Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children — Completed